FemTherapeutics is winner SAGES 2025 Shark Tank competition at its annual meeting in Long Beach, Calif.
Montreal-based FemTherapeutics https://femtherapeutics.com/ is on a mission to provide personalized, accessible, and effective solutions to common pelvic health conditions.
Their first product is a personalized intravaginal prosthetic (pessary) designed to manage Pelvic Organ Prolapse, which affects 50% of women at some point in their lives. Unlike traditional, one-size-fits-all options, FemTherapeutics’ pessaries are individually tailored to each patient’s anatomy and lifestyle, prioritizing accessibility while setting a new standard for comfort and effectiveness.
FemTherapeutics is building the infrastructure to allow expansion into other pelvic health categories including incontinence, pelvic pain, and maternal health; and is redesigning the patient experience through hybrid care delivery models.
“Participating in SAGES was an invaluable experience and receiving direct feedback from a panel of physicians made it even more meaningful – something that is unique to SAGES,” said Negin Ashouri, FemTherapeutics co-founder and Chief Technology Officer. The judges’ insights provided critical early validation, strengthening the importance of our work in advancing women’s health. We are honored to have been chosen as winners and grateful for the judges’ trust in us and our mission.”
“FemTherapeutics has created a product that addresses a concern for many women that’s poorly met with existing alternatives,” said SD Schwaitzberg, MD, FACS. “The judges were impressed with the simplicity and ingenuity of the product, coupled with its potential market size and multiple distribution pathways.”
SAGES Shark Tank competition is designed to support clinicians focused on commercializing their innovations through investment capital, including by sale to a third party and not primary scientific research. In partnership with Varia Ventures, SAGES continues to educate its members on entrepreneurism, engage and showcase inventors through the reimagined and funded SAGES Shark Tank, and finance promising startups through SAGES Investment Network Collaborative (SINC). SAGES members can participate in SINC through https://varia.com/sinc/.
Along with FemTherapeutics, this year’s finalists included Suture Shield, Qaelon and Evolving Education, all of whom presented their supporting business models to the Shark Tank judges that included Drs. Schwaitzberg and Jon Gould, Carla Pugh and Danielle Walsh from SAGES, and Scott Friedman from Varia Ventures and Dennis McWilliams, founder of Apollo Endosurgery. As in previous years, FemTherapeutics’ winning prize money is $30,000.